Deep Learning for the Diagnosis and Treatment of Thyroid Cancer: A Review.
Authors
Affiliations (4)
Affiliations (4)
- Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- The School of Interdisciplinary Studies, Lingnan University, Hong Kong, China.
- Department of Critical Care Medicine Comprehensive Ward One, Central People's Hospital of Zhanjiang, Zhanjiang, China.
- Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: [email protected].
Abstract
In recent years, the application of deep learning (DL) technology in the thyroid field has shown exponential growth, greatly promoting innovation in thyroid disease research. As the most common malignant tumor of the endocrine system, the precise diagnosis and treatment of thyroid cancer has been a key focus of clinical research. This article systematically reviews the latest research progress in DL research for the diagnosis and treatment of thyroid malignancies, focusing on the breakthrough application of advanced models such as convolutional neural networks (CNNs), long short-term memory networks (LSTMs), and generative adversarial networks (GANs) in key areas such as ultrasound images analysis for thyroid nodules, automatic classification of pathological images, and assessment of extrathyroidal extension. Furthermore, the review highlights the great potential of DL techniques in the development of individualized treatment planning and prognosis prediction. In addition, it analyzes the technical bottlenecks and clinical challenges faced by current DL applications in thyroid cancer diagnosis and treatment and looks ahead to future directions for development. The aim of this review is to provide the latest research insights for clinical practitioners, promote further improvements in the precision diagnosis and treatment system for thyroid cancer, and ultimately achieve better diagnostic and therapeutic outcomes for thyroid cancer patients.